William Grossman Arcus Biosciences, Inc. (RCUS) insider trading activity

William Grossman is Chief Medical Officer of Arcus Biosciences, Inc.. Currently has a direct ownership of 20,723 shares of RCUS, which is worth approximately $316,440. The most recent transaction as insider was on Jun 17, 2021, when has been sold 3,891 shares (Common Stock) at a price of $23.68 per share, resulting in proceeds of $92,139. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.7K

0% 3M change

0% 12M change

Total Value Held $316,440

William Grossman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 17 2021	SELL Open market or private sale	$92,139 $23.68 p/Share	3,891 Reduced 15.81%	20,723 Common Stock
Jun 16 2021	SELL Open market or private sale	$77,604 $24.45 p/Share	3,174 Reduced 11.42%	24,614 Common Stock
Apr 23 2021	SELL Open market or private sale	$129,652 $31.37 p/Share	4,133 Reduced 38.09%	6,717 Common Stock
Mar 16 2021	SELL Open market or private sale	$74,509 $35.03 p/Share	2,127 Reduced 16.39%	10,850 Common Stock
Jan 19 2021	BUY Grant, award, or other acquisition	-	18,750 Added 42.39%	25,477 Common Stock
Dec 16 2020	SELL Open market or private sale	$66,368 $31.35 p/Share	2,117 Reduced 23.94%	6,727 Common Stock
Oct 02 2020	BUY Grant, award, or other acquisition	-	100,000 Added 49.85%	100,600 Common Stock

Also insider at

DAWN

Day One Biopharmaceuticals, Inc. Healthcare